Protocol Ledger

NCT05121324 · Phase III · RECRUITING

Pediatric Dose Optimization for Seizures in Emergency Medical Services

Interventional Phase III clinical trial protocol NCT05121324 sponsored by Stanford University in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-08-08 Enrollment: 6,700 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05121324
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)6,700 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05121324
Protocol FieldVerified Registry Value
NCT IdentifierNCT05121324
Consolidated Lead SponsorStanford University
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment6,700 participants (ESTIMATED)
Registered Start Date2022-08-08
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI